Skip to content

Bio-Europe Fall 2023

Event Information:


November 6th to 8th, 2023

Munich, Germany

Related Models & Services

CD34+ Humanized Mouse
Immuno-Oncology Models

Unlock the Future of Preclinical Research: Join TransCure BioServices at BIO-Europe Fall 2023!

Explore a world of cutting-edge preclinical research opportunities with TransCure BioServices’ humanized mouse models at BIO-Europe Fall 2023! Join us in Munich, Germany, from November 6–8, 2023. The 29th annual BIO-Europe Fall will bring together more than 5,000 life science professionals 5,000 life science professionals from over 2,220 companies representing 60 countries. Throughout the event, attendees will have the opportunity to participate in 27,000 one-to-one meetings.

During BIO-Europe, immerse yourself in various topics, including Therapeutics insight, Pharma’s future, AI’s impact, cell and gene therapy, and emerging global market opportunities. Hear firsthand from key biotech and pharma leaders about the latest industry trends.

Visit us, let’s discuss the potential of our humanized mouse models in advanced preclinical research, revolutionizing cancer treatment, combating inflammatory diseases, and developing HIV vaccines. Our scientific expert Ha-Yeon Kim-Penard, PhD, Business Developer will be on hand to discuss studies designs and demonstrate the potential of our models in shaping groundbreaking treatments.

Additionally, mark your calendar for the virtual side meeting organized by Bio-Europe Fall and the EBD Group from November 14–15, 2023.

We look forward to meeting you at BIO-Europe Fall 2023 in Munich! Let’s join forces to shape the future of preclinical research!

Stay tuned for more updates and information on our stand location and schedule.

Ha-Yeon Kim-Penard, PhDAttending in person for TransCure bioServices:

Ha-Yeon Kim-Penard, PhD, Business Development

Ha-Yeon Kim-Penard holds a PhD in Cell and Molecular Biology from the University of Paris, in France. She worked at the Curie Institute (Orsay, France) in the field of cancer biology in cutaneous melanoma, before joining the TransCure bioServices Team as Project Leader in 2020. She has led many projects including immuno-oncology, infectious diseases, humanized liver models, and GvHD in mouse models.

This event has concluded